GW Pharmaceuticals Plc (GWPH)

147.35
5.51 3.60
NASDAQ : Health Technology
Prev Close 152.86
Open 152.51
Day Low/High 146.33 / 152.94
52 Wk Low/High 90.14 / 196.00
Volume 624.52K
Avg Volume 375.70K
Exchange NASDAQ
Shares Outstanding 30.72M
Market Cap 4.63B
EPS -9.60
P/E Ratio N/A
Div & Yield N.A. (N.A)
Off the Charts

Off the Charts

9/02/14: Baidu BIDU exploded to the upside today and hit our stop price at $222. We are removing it from our short ideas list with a loss of 3.38%.

Off the Charts

Off the Charts

Baidu exploded to the upside today, while GW Pharmaceuticals broke down.

GW Pharmaceuticals Plc Reports 2014 Third Quarter Financial Results

GW Pharmaceuticals Plc Reports 2014 Third Quarter Financial Results

Conference Call Today at 8:00 a.m. ET, 1:00 p.m. BST

Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom

Jim Cramer's 'Mad Money' Recap: Unconventional Wisdom

Should investors settle for average results? Absolutely not, Cramer says.

'Mad Money' Lightning Round: Buy, Buy, Buy Reynolds American

'Mad Money' Lightning Round: Buy, Buy, Buy Reynolds American

Cramer is bullish on Sunoco Logistics Partners and Sanchex Energy but he would not own Tumi Holdings.

Jim Cramer's 'Mad Money' Recap: Don't Panic, Just Wait

Jim Cramer's 'Mad Money' Recap: Don't Panic, Just Wait

There's no reason to start selling but there's also no reason to run out and buy either, Cramer says.

We Need to Talk About Russell

The small-cap index appears to be setting up an oversold rally.

Jim Cramer's 'Mad Money' Recap: Clear the Slate for Earnings Season

Jim Cramer's 'Mad Money' Recap: Clear the Slate for Earnings Season

Starting next week, stocks will only move higher if companies can beat on the top and bottom lines and raise guidance for the rest of the year, Cramer said.

Cramer: Can't Take the Heat? Get Out of Specs

Cramer: Can't Take the Heat? Get Out of Specs

Accept the risk you're taking on and, above all, be a grown-up about it.

Can't Take the Heat? Get Out of Specs

Accept the risk you're taking on and, above all, be a grown-up about it.

'Mad Money' Lightning Round: American Airlines Delivers

'Mad Money' Lightning Round: American Airlines Delivers

Cramer is avoiding Annaly Capital, warns GW Pharmaceuticals could have ups and down and likes Ensco over Transocean.

Jim Cramer's 'Mad Money' Recap: Buy, Don't Sell, on European Weakness

Jim Cramer's 'Mad Money' Recap: Buy, Don't Sell, on European Weakness

It's not 2008 anymore and one Portugal bank's problems is no reason to panic, Cramer says.

A No-Drama Market

Not much reason to sell right now.

GW Pharma Rises After Analyst Sees Promise in Marijuana-Derived Epilepsy Drug

GW Pharma Rises After Analyst Sees Promise in Marijuana-Derived Epilepsy Drug

Shares of GW Pharmaceuticals (GWPH) are climbing after research firm Piper Jaffray sharply raised its price target on the stock after speaking with epilepsy specialists.

Jim Cramer's Stop Trading: 'Amazed' by GW Pharmaceuticals

Jim Cramer's Stop Trading: 'Amazed' by GW Pharmaceuticals

TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, says GW Pharmaceuticals' epilepsy treatment could be used for other diseases too.

Why GW Pharmaceuticals (GWPH) Stock Is Rising Today

Why GW Pharmaceuticals (GWPH) Stock Is Rising Today

GW Pharmaceuticals (GWPH) shares are up after having its price target increased to $147 by analysts at Piper Jaffray (PJC).

Why I'm Not High on GW Pharma

Forget marijuana, there's a more basic reason to be bearish.

Jim Cramer's Top Stock Picks: MON GIS PPG EOG UNP GWPH STZ

Jim Cramer's Top Stock Picks: MON GIS PPG EOG UNP GWPH STZ

Cramer is high on GW Pharmaceuticals and will be watching for Monsanto's and General Mills' earnings next week.

'Fast Money' Recap: Muddling Along to Another All-Time High

'Fast Money' Recap: Muddling Along to Another All-Time High

The trading panel discussed the health of the U.S. consumer and which stocks to avoid for the summer.

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan

Cramer will be watching Chinese economic data, company earnings and other things to get investors excited next week.

Jim Cramer's Stop Trading: GW Pharmaceuticals Is 'A Winner'

Jim Cramer's Stop Trading: GW Pharmaceuticals Is 'A Winner'

TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, takes a look at GW Pharmaceuticals' secondary offering and outlines the bull case for the company.

Jim Cramer's Stop Trading: Buy GW Pharmaceuticals, Not ConAgra Foods

Jim Cramer's Stop Trading: Buy GW Pharmaceuticals, Not ConAgra Foods

TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, says investors should buy GW Pharmaceuticals on its secondary offering. He did not like ConAgra Foods earnings results.

'Fast Money' Recap: Waiting on the Fed

'Fast Money' Recap: Waiting on the Fed

The trading panel discussed what one perceived hawkish comment from the central bank could do to stocks and bonds.